ABCB1 and lung carcinoma: Since it has been reported that alectinib has exhibited promising activity in lung cancer patients with brain metastasis37, our data might support the speculation that the intact brain transitivity of drugs or the substrate property of MDR1 do not directly correlate with the drug penetration and treatment efficacy in brain metastatic tumors17, 38.